Toolkit | May 17, 2018 | Human Health, Biodefense and Vaccines
Certain infectious disease products have limited or no commercial market. No one incentive will address all challenges. A suite of push and pull incentives are needed to address market challenges to the research and development of vaccines, antimicrobials, therapeutics, diagnostics and novel…